Design optimization for clinical trials in early-stage manifest Huntington's disease.
Frost C, Mulick A, Scahill RI, Owen G, Aylward E, Leavitt BR, Durr A, Roos RAC, Borowsky B, Stout JC, Reilmann R, Langbehn DR, Tabrizi SJ, Sampaio C; TRACK-HD Investigators.
Frost C, et al. Among authors: scahill ri.
Mov Disord. 2017 Nov;32(11):1610-1619. doi: 10.1002/mds.27122. Epub 2017 Sep 14.
Mov Disord. 2017.
PMID: 28906031